CRI-IMIDIATE is an excellence network specialized in clinical investigation dedicated to systemic and articular inflammatory diseases. (IMIDs for Immune-Mediated Inflammatory Diseases). The network gathers centers specialized in internal medicine and rheumatology.
- Clinical studies and therapeutic tests in rare inflammatory diseases such as systemic lupus, Still's disease and other sporadic auto-inflammatory diseases, myositis, systemic scleroderma, Sjögren syndrome as well as systemic vasculitis.
- Clinical studies and tests for therapeutic strategies in inflammatory rheumatisms (rheumatoid polyarthritis, spondyloarthritis, psoriatic arthritis)
- Evaluation of the ratio benefits/risks of immunomodulators in this domain.
A reference network of excellence in clinical research
CRI-IMIDIATE is an outcome of the RIC (Rheumatisms & Inflammation Club) founded in 1995 by several rheumatologists. This network is composed of certified centers which cover France linking neighboring regions.
CRI-IMIDIATE has been recently labelled by the European program F-CRIN (French Clinical Research Investigation Network) and is connected to other structures belonging to the program such as the platform PARTNERS, the networks I-REIVAC, INNOVTE or the transversal structure ORPHANDEV…
This is an excellence clinical investigation network which structures and organizes university and industrial clinical research. CRI-IMIDIATE is also connected to the care system FAI2R which is dedicated to auto-immune and rare auto-inflammatory diseases.